When was Sagent Pharma founded?

Sagent Pharma was founded in 2006 and raised its 1st funding round 1 year after it was founded.

Where is Sagent Pharma located?

Sagent Pharma is headquartered in Schaumburg, United States. It is registered at Schaumburg, Illinois.

Who is the current CEO of Sagent Pharma?

Jeffrey Yordon and Allan Oberman s of Sagent Pharma.

How many employees does Sagent Pharma have?

As of Sep 30, 2026, the latest employee count at Sagent Pharma is 220.

Is Sagent Pharma a funded company?

Sagent Pharma is a funded company, having raised a total of $153M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Sep 26, 2007.

When was the latest funding round of Sagent Pharma?

Sagent Pharma's latest funding was a $***** Series B round on Apr 05, 2010, with participation from 1 investor.

What is the annual revenue of Sagent Pharma?

Annual revenue of Sagent Pharma is between $100M and $500M as on Dec 31, 2015

Where does Sagent Pharma rank among its competitors?

Sagent Pharma ranks 2nd amongst 89 active competitors, of which 5 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Exela Pharma, which secured $28.3M in Sep, 2025.

Who are the top competitors of Sagent Pharma?

Sagent Pharma's top competitors include Gufic Group, JAMP Pharma and ImprimisRx. Among them, Exela Pharma secured the most recent funding round in September, 2025.

Sagent Pharma - 2026 Company Profile, Team, Funding, Competitors & Financials

Sagent Pharma is an acquired company based in Schaumburg (United States), founded in 2006 by Jeffrey Yordon. It operates as a Provider of injectable generic pharmaceuticals. Sagent Pharma has raised $153M in funding from Zhejiang Hisun Pharmaceuticals. The company has 89 active competitors, including 5 funded and 24 that have exited. Its top competitors include companies like Gufic Group, JAMP Pharma and ImprimisRx.

Company Details

Provider of injectable generic pharmaceuticals. This company offers a portfolio of products spanning multiple therapeutic categories and various packaging configurations, including vials, syringes, and premix bags. They are dedicated to meeting the needs of patients and healthcare providers. The company also offers smart labeling to help reduce medication errors. Their team provides support to customers within the healthcare system.

Website: www.sagentpharma.com/
Registered Address: Schaumburg, Illinois

Key Metrics

Founded Year

2006

Location

Schaumburg, United States

Stage

Acquired

Total Funding

$153M in 5 rounds

Latest Funding Round

Series B, Apr 05, 2010, $*****

Investors

Zhejiang Hisun Pharmaceuticals & 4 more

Ranked

2^nd among 89 active competitors

Annual Revenue

$100M - $500M as on Dec 31, 2015

Employee Count

220 as on Sep 30, 2026

Investment & Acquisitions

Omega Laboratories

Similar Companies

Gufic Group & 98 more

Exit Details

Acquired by Nichi-Iko Pharmaceutical (Jul 10, 2016)

View Sagent Pharma's full profile

Sagent Pharma is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
SAGENT PHARMACEUTICALS, INC. CIN: 1369786 , United States, Active		$100M - $500M (As on Dec 31, 2015)	-	-
SAGENT PHARMACEUTICALS INC CIN: 205522946 , United States, Active	Dec 26, 999	-	119 (As on Dec 31, 2024)	-

Sagent Pharma got acquired by Nichi-Iko Pharmaceutical on Jul 10, 2016.

Click here to take a look at Sagent Pharma's acquisition in detail

Sagent Pharma has raised a total funding of $153M over 5 rounds. Its first funding round was on Sep 26, 2007. Its latest funding round was a Series B round on Apr 05, 2010 for $*****. 1 investor participated in its latest round. Sagent Pharma has 5 institutional investors.

Here is the list of recent funding rounds of Sagent Pharma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 05, 2010	4006976	Series B	2256824	6937233	8426214	1844475
Jun 19, 2009	3767752	Venture Debt	9253239	5925297	7203226	MidCap Financial
May 20, 2009	9627058	Series A	8158880	8329360	1936143	Vivo Capital

Access funding benchmarks and valuations. Sign up today!

View details of Sagent Pharma's funding rounds and investors

The founders of Sagent Pharma is Jeffrey Yordon.

Here are the details of Sagent Pharma's key team members:

Jeffrey Yordon: Chairman/CEO/ Founder of Sagent Pharma.
Allan Oberman: Co-Founder of Sagent Pharma.

View details of Sagent Pharma's Founder profiles and Board Members

Sagent Pharma's employee count trend

Sagent Pharma has 220 employees as of Sep 26. Here is Sagent Pharma's employee count trend over the years:

Uncover Sagent Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sagent Pharma include Gufic Group, JAMP Pharma and ImprimisRx. Here is the list of Top 10 competitors of Sagent Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Gufic Group 1970, Mumbai (India), Public	Manufacturer of lyophilized injections and pharmaceutical products	-	-	52/100
2nd	Sagent Pharma 2006, Schaumburg (United States), Acquired	Provider of injectable generic pharmaceuticals	$153M	MidCap Financial, Vivo Capital & 3 others	51/100
3rd	JAMP Pharma 1988, Boucherville (Canada), Late Stage	Manufacturer of injectables	-	Fonds de solidarite FTQ	51/100
4th	ImprimisRx 1998, Roxbury Township (United States), Seed	Developer of proprietary sterile and topical drug formulations	$80K	-	50/100
5th	Kelun Pharmaceutical 1996, Chengdu (China), Public	Manufacturer of pharmaceutical products and related services	-	Yonghua Capital	49/100
6th	Innopharma 2005, Piscataway (United States), Acquired	Manufacturer of injectable pharmaceutical products	$23M	Thomas, McNerney & Partners, Comerica & 1 others	49/100
7th	Nanolek 2011, Moscow (Russia), Late Stage	Manufacturer of biopharmaceuticals and vaccines	$43.7M	Sberbank, Rusnano	48/100
8th	Otsuka Pharmaceutical India 2012, Ahmedabad (India), Unfunded	Manufacturer of intravenous infusions and clinical nutrition products	-	-	48/100
9th	Exela Pharma 2005, Lenoir (United States), Series B	Manufacturer of sterile injectable pharmaceutical products and CDMO services	$6.67M	Trinity Capital, Baruch Future Ventures & 3 others	46/100
10th	Amphastar Pharmaceuticals 1996, Rancho Cucamonga (United States), Public	Manufacturer of injectable and inhalation products	-	YFY, Yet2ventures & 2 others	46/100